Pharma Focus Asia

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

GSK Enters Into A Multi-Year Data Licence Agreement With Ochre Bio To Further Investigate The Drivers Of Liver Disease

Thursday, June 13, 2024

Ochre Bio a pioneer in chronic liver disease medicine development has today announced the start of a multiyear data licence agreement with GSK The partnership will provide GSK with access to Ochre Bios

OBI Pharma Announces Phase 1/2 Study Initiation for OBI-992, a TROP2-Targeted Antibody-Drug Conjugate (ADC) for Cancer Therapy

Thursday, June 13, 2024

OBI Pharma a clinicalstage oncology company today announced the initiation of a Phase clinical trial of OBI an antibodydrug conjugate targeting TROP

Sibylla Biotech and MD Anderson Announce Strategic Collaboration to Discover and Develop Small-Molecule Protein Degraders

Thursday, June 13, 2024

Sibylla Biotech and The University of Texas MD Anderson Cancer Center today announced a strategic collaboration agreement to discover and develop novel smallmolecule cancer therapies

Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japan

Thursday, June 13, 2024

Belite Bio Inc a clinicalstage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs

Bespak Reaches Key Milestone in the Expansion of Its Manufacturing Capacity, With Further Expansion Plans Underway to Meet Global Customer Demand for Climate Friendly Inhalers

Wednesday, June 12, 2024

Bespak a leading contract development and manufacturing organisation focused on orally inhaled

New AI Tool Finds Rare Variants Linked to Heart Disease in 17 Genes

Wednesday, June 12, 2024

Using an advanced artificial intelligence tool researchers at the Icahn School of Medicine at Mount Sinai have identified rare coding variants in genes that shed light on the molecular basis of coronary artery disease the leading cause of morbidity...

Lokavant Launches First AI Clinical Trial Feasibility Solution to Optimize Trials From Strategic Planning to Mid-Study Re-forecasting

Wednesday, June 12, 2024

Lokavant the clinical trial intelligence platform company today announced Spectrum the first AI clinical trial feasibility software solution for trial optimization across the entire clinical development value chain

NurExone Announces Expansion of ExoPTEN Patent Coverage with Notice of Allowance for Japanese Patent Application

Wednesday, June 12, 2024

NurExone Biologic Inc a pioneering biopharmaceutical company developing regenerative medicine therapies is pleased to announce that the Japan

Global Registrational Phase III Study of Olverembatinib for the Treatment of Patients with SDH-Deficient GIST Approved by the China CDE

Tuesday, June 11, 2024

Ascentage Pharma a global biopharmaceutical company engaged in developing novel therapies for cancer chronic hepatitis B and agerelated diseases announced today that the Center for Drug Evaluation

Shaperon and Dong-A ST Sign MOU for Nanobody-Based New Drug Development

Tuesday, June 11, 2024

Hudson Therapeutics announced that Shaperon an innovative biopharmaceutical company specializing in immune therapeutics has signed a Memorandum of Understanding with DongA ST KOSPI CEO MinYoung Kim for the development of nanobodybased new drugs

magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Advanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024